secwatch.observer — SEC 8-K summary
======================================

Issuer:     UroGen Pharma Ltd. (URGN)
CIK:        0001668243
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001193125-23-193453
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

UroGen appoints James A. Robinson Jr. to Board, increasing size to 9 directors
------------------------------------------------------------------------------

- Board increased from 8 to 9; Robinson appointed to fill vacancy and serve on Compliance Committee.
- Initial option grant of 20,000 ordinary shares, vesting quarterly over 12 quarters.
- Annual retainer of $40,000 plus $5,000 for Compliance Committee service.
- Eligible for annual option grant of 10,000 shares at each annual shareholder meeting.
- Standard indemnity agreement will be entered with Robinson.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668243/000119312523193453/0001193125-23-193453-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668243/000119312523193453/d480915d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-193453

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer